Icu Medical (ICUI) Non-Current Assets (2009 - 2026)
Icu Medical's (ICUI) quarterly Non-Current Assets came in at $2.8 billion in Q2 2026, down 5.7% on a YoY basis from $2.9 billion in Q2 2025, and down 1.43% quarter-over-quarter from $2.8 billion in Q1 2026.
Analysis
Icu Medical (ICUI) Non-Current Assets (2009 - 2026) Analysis & Trends
Icu Medical (ICUI) has reported Non-Current Assets for 18 consecutive years, with $2.8 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets fell 5.7% year-over-year to $2.8 billion; the trailing twelve-month figure through Jun 2026 stood at $11.3 billion (down 1.57% YoY), and the FY2025 full-year result was $2.9 billion, up 3.55% from the prior year.
- Non-Current Assets retreated to $2.8 billion in Q2 2026 per ICUI's latest filing, from $2.8 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $3.6 billion in Q1 2022 and bottomed at $2.8 billion in Q2 2026.
- Historically, Non-Current Assets has averaged $3.1 billion across 5 years, with a median of $3.1 billion in 2024.
- The sharpest annual moves came in 2022 and 2024: Non-Current Assets soared 326.83% in 2022, then retreated 12.52% in 2024.
- Over 5 years, Non-Current Assets stood at $3.3 billion in 2022, then fell by 3.76% to $3.2 billion in 2023, then declined by 12.52% to $2.8 billion in 2024, then increased by 3.55% to $2.9 billion in 2025, then slipped by 3.48% to $2.8 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $2.8 billion, $2.8 billion, and $2.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 2.37 Bn |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 4.64 Bn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | 24.47 Bn |
| 10 | Icu Medical | 3.82 Bn | 3.52 Bn | 235.05 Mn | 2.76 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.76 Bn |
| Mar 31, 2026 | 2.80 Bn |
| Dec 31, 2025 | 2.86 Bn |
| Sep 30, 2025 | 2.90 Bn |
| Jun 30, 2025 | 2.93 Bn |
| Mar 31, 2025 | 2.76 Bn |
| Dec 31, 2024 | 2.76 Bn |
| Sep 30, 2024 | 3.05 Bn |
| Jun 30, 2024 | 3.05 Bn |
| Mar 31, 2024 | 3.10 Bn |
| Dec 31, 2023 | 3.16 Bn |
| Sep 30, 2023 | 3.16 Bn |
| Jun 30, 2023 | 3.22 Bn |
| Mar 31, 2023 | 3.26 Bn |
| Dec 31, 2022 | 3.28 Bn |
| Sep 30, 2022 | 3.25 Bn |
| Jun 30, 2022 | 3.40 Bn |
| Mar 31, 2022 | 3.57 Bn |
| Dec 31, 2021 | 850.93 Mn |
| Sep 30, 2021 | 828.11 Mn |